跳至主要内容
临床试验/CTRI/2014/07/004800
CTRI/2014/07/004800招募中4 期

The efficacy and adverse drug profile of Risperidone versus Olanzapine in the treatment of patients with bipolar affective disorder on combination therapy - A prospective, naturalistic, hospital based clinical study.

Dr Manjuprasad0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Pms

入排标准

入选标准

  • (1) patients on above mentioned age groups and sex
  • (2)Patients on mood stabilizer Divalproaex sodium

排除标准

  • (1)Age less than 18yrs and more than 65yrs.
  • (2)Serious medical disorders endangering life.
  • (3)Judged clinically to be at serious suicidal risk.
  • (4)Patients on mood stabilizer other than divalproaex sodium

研究者

发起方
Dr Manjuprasad

相似试验